Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
Conditions: Stage IV Melanoma; Advanced Lung Cancer; Stage IV Non-Small Cell Lung Cancer; Unresectable Non-Small Cell Lung Carcinoma; Unresectable Stage III Non-Small Cell Lung Cancer; Small Cell Lung Cancer Extensive Stage; Stage IV Merkel Cell Carcinoma; Stage IV Cutaneous Squamous Cell Carcinoma; Stage IV Basal Cell Carcinoma; Stage IV Breast Cancer; Stage IV Colorectal Cancer; Stage IV Gastric Cancer; Stage IV Esophageal Cancer; Stage IV Hepatocellular Cancer; Stage IV Renal Cell Carcinoma; Stage IV Bladder Cancer; Stage IV Head and Neck Squamous Cell Carcinoma; Stage IV Cervical Cancer; Stage IV Endometrial Cancer; Stage IV Mesothelioma; Immunotherapy; Immune Checkpoint Inhibitors
Interventions: Other: Educational Video and QPL List; Other: Usual Care
Sponsors: Massachusetts General Hospital; Conquer Cancer Foundation
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.